CT Lung Cancer Screening (Low-Dose) — Dictation, Appropriateness, and Dose for Residents
1. The Grind of the Screening List
It’s 3 PM on a Tuesday. You’ve got a list of ten low-dose CT lung cancer screenings to read before you can even think about the rest of the queue. Each one has a prior. Each one has tiny nodules that might have grown by a fraction of a millimeter. Your attending expects a perfect Lung-RADS classification on every single one, including the S modifier for coronary calcium or emphysema. Get one wrong, and a patient either gets a needless biopsy or a delayed diagnosis. No pressure. This isn’t about finding the zebra; it’s about meticulous, high-stakes comparison, over and over. When you’re trying to be efficient and accurate, having a solid framework is everything. We’ve built out guides like this one, plus calculators and other tools, in the residents and fellows resource hub to help you stay sharp on call and on service.
2. What a Low-Dose CT Lung Cancer Screening Covers and What Attendings Look For
A Low-Dose Computed Tomography (LDCT) for lung cancer screening is an annual, non-contrast chest CT designed to detect early-stage, curable lung cancers in high-risk individuals before they become symptomatic. The eligibility criteria are specific and driven by major national guidelines (USPSTF, CMS).
When your attending co-signs your report, they are looking for a few key things, all of which must be explicitly addressed:
- Lung-RADS Classification: The core of the report. Every significant nodule needs to be measured and tracked, culminating in a final Lung-RADS category (1, 2, 3, 4A, 4B, or 4X) that dictates the patient’s next step.
- Comparison to Priors: This is non-negotiable. The change in nodule size or morphology (e.g., new solid component) is what drives an upgrade in the Lung-RADS category. You must state the date of the comparison study.
- Significant Incidental Findings (S Modifier): The “S” modifier is added to the Lung-RADS category for clinically significant findings outside of lung cancer, such as moderate-to-severe emphysema, significant coronary artery calcification (e.g., Agatston score ≥100), or aortic disease.
- Clear Follow-up Recommendation: The impression must state the exact follow-up plan based on the Lung-RADS category (e.g., “Continue annual LDCT screening,” “6-month follow-up LDCT,” or “Consider PET/CT or biopsy”).
3. Radiology Report Template for Low-Dose CT Lung Cancer Screening
This template is a solid starting point for your macros. Remember to tailor the findings to the specific case. The key principles below are your guardrails for dictating an accurate and useful report.
Key Dictation Principles:
- Always compare to ALL available prior LDCT screening studies. Change over time is the most critical factor.
- Volumetric measurement is more accurate than 2D diameters for tracking growth, especially for subsolid nodules. Use it if your PACS supports it.
- A new or growing solid nodule >6 mm, or a part-solid nodule >6 mm with a solid component >4 mm, will likely be a Lung-RADS 3 or 4.
- Always document significant non-cancer findings and apply the Lung-RADS S modifier. This includes emphysema severity, coronary artery calcium, and aortic pathology.
- Remember that pure ground-glass, part-solid, and solid nodules have different management pathways within the Lung-RADS system.
Technique
Low-dose, non-contrast helical CT of the chest was performed from the lung apices through the lung bases during a single inspiratory breath-hold. Images were reconstructed using iterative reconstruction techniques. Dose reduction techniques were utilized. The effective radiation dose for this examination was approximately [1.0-1.5] mSv.
Findings
COMPARISON: [Date of prior study]
LUNGS AND AIRWAYS:
Nodules: [Describe location, size in 3D, morphology (solid, part-solid, ground-glass), and any change from prior. e.g., “Right upper lobe 5 mm solid noncalcified pulmonary nodule, stable.” or “Left lower lobe 7 mm part-solid nodule with a 4 mm solid component, previously pure ground-glass measuring 6 mm.”]
Parenchyma: [e.g., No consolidation, atelectasis, or effusion. Describe emphysema if present, e.g., “Mild centrilobular emphysema.”]
Airways: Trachea and central bronchi are patent.
PLEURA: No pleural effusion or pneumothorax.
MEDIASTINUM AND HILA: No mediastinal or hilar lymphadenopathy. The thyroid gland is unremarkable. The esophagus is nondilated.
HEART AND GREAT VESSELS:
Coronary Artery Calcification: [None, mild, moderate, or severe. If quantified, provide Agatston score.]
Aorta: [e.g., “Thoracic aorta is normal in caliber.” or “Ascending thoracic aorta measures up to 4.2 cm, ectatic.”]
Pericardium: No pericardial effusion.
CHEST WALL AND UPPER ABDOMEN: Visualized osseous structures are unremarkable. Visualized portions of the upper abdomen are unremarkable.
Impression
1. [e.g., Stable 5 mm solid nodule in the right upper lobe.]
2. [e.g., Moderate coronary artery calcification.]
LUNG-RADS ASSESSMENT: Category [2, Benign Appearance or Behavior]. S Modifier (due to coronary artery calcification).
RECOMMENDATION: Continue annual low-dose CT screening.
4. Free Template Sources from the Radiology Community
Building your own macro library is a rite of passage, but you don’t have to start from scratch. Before considering any paid tool, you should know that two great free repositories exist, curated by and for radiologists. They are excellent resources for building out your personal template library for this and hundreds of other studies.
- RadReport.org: The RSNA-managed library. It’s comprehensive, peer-reviewed, and the closest thing we have to an official source for structured templates.
- Radiology Templates (AU): An excellent, clean, and well-organized library maintained by Australian radiologists. It’s practical and covers a huge range of common studies.
5. The Next-Level Move: From Free-Form to Flawless
The templates above are static. You still have to find the right one, copy it, and manually edit every bracketed field. When you’re reading a dozen screenings in a row, that friction adds up. The real bottleneck is converting your free-form dictation of positive findings—”7 millimeter part-solid nodule in the RUL with a new 4 millimeter solid component”—into a perfectly structured report with the right Lung-RADS score and follow-up recommendation.
This is where AI-assisted reporting tools can make a difference. Instead of you hunting for the right template, GigHz Precision AI is designed to listen to your dictated findings and automatically generate a clean, structured report based on pre-loaded ACR and society guidelines. It helps ensure that critical elements like nodule measurements, comparison to priors, and the final Lung-RADS classification are captured consistently every time. It’s about reducing the manual editing so you can focus on the diagnostic task.
6. When Should You Order a Low-Dose CT Lung Cancer Screening? ACR Appropriateness Criteria
The American College of Radiology (ACR) provides evidence-based guidelines to help referring clinicians choose the right exam. For lung cancer screening, the criteria are well-defined and closely follow USPSTF recommendations.
According to the ACR Appropriateness Criteria for Lung Cancer Screening, an annual LDCT is Usually Appropriate (ACR rating 7/9) for the primary screening population: asymptomatic patients aged 50 to 80 with at least a 20 pack-year smoking history who currently smoke or have quit within the past 15 years. This is the bread-and-butter indication you’ll see every day.
The ACR also considers other scenarios. For a patient younger than 50 who has a 20+ pack-year history and at least one additional risk factor (like radon exposure, occupational exposure, personal cancer history, or family history of lung cancer), LDCT is also considered Usually Appropriate (ACR rating 7/9).
However, for patients with a less significant smoking history (less than 20 pack-years) and no other risk factors, the benefit is less clear, though the ACR still rates LDCT as Usually Appropriate in this scenario as well, acknowledging the complexity of risk assessment. It’s crucial to remember that screening is for asymptomatic individuals; patients with symptoms concerning for lung cancer (e.g., hemoptysis, new cough, weight loss) require a diagnostic chest CT, not a screening LDCT.
7. How Much Radiation Does a Low-Dose CT Lung Cancer Screening Deliver?
A common patient question is about radiation dose, and you need to have a clear, confident answer. A low-dose CT lung cancer screening delivers an estimated effective dose of 1 to 1.5 mSv.
To put that in perspective, it’s significantly less than a standard diagnostic chest CT (which is around 7 mSv). It’s about half the dose of a screening mammogram and equivalent to about one-third of the average annual background radiation a person receives just from living on Earth (~3 mSv/year). This low dose is achieved by using reduced tube current (mAs) and often lower tube voltage (kVp), with advanced iterative reconstruction software cleaning up the resulting image noise.
| Imaging Study / Exposure | Typical Effective Dose (mSv) |
|---|---|
| Low-Dose CT Lung Screening | 1.0 – 1.5 mSv |
| Chest X-ray (2 views) | 0.1 mSv |
| Screening Mammogram | ~2.5 mSv |
| Annual Natural Background Radiation | ~3 mSv |
| Standard Diagnostic Chest CT | ~7 mSv |
The entire principle of screening is predicated on this low-dose technique, making the benefit of early cancer detection far outweigh the minimal radiation risk for the eligible high-risk population.
8. Low-Dose CT Lung Cancer Screening Imaging Protocol — Phases, Contrast, and Reconstructions
A successful LDCT screening protocol is all about minimizing radiation while maintaining sufficient image quality for nodule detection and characterization. It is a non-contrast, single-acquisition study. The key is using low mAs and leveraging iterative reconstruction to produce diagnostic-quality images.
| Phase / Sequence | Coverage | Key Parameters | Breath-Hold |
|---|---|---|---|
| Topogram (Scout) | Thorax | AP and Lateral views, 120 kVp | Inspiration |
| Low-Dose Helical Chest | Apices to Bases | kVp: 100-120; mAs: 30-60 (low); Pitch: ~1.2; Iterative Reconstruction: 50-80% | Single Inspiration |
| Reconstructions | Full Volume | Axial: 1-1.5 mm (Lung & Soft Tissue Kernels); MPR: 3 mm Sagittal & Coronal | N/A |
Common protocol pitfalls:
- Inadequate Inspiration: A poor breath-hold can create atelectasis at the lung bases, which can mimic or obscure true nodules. Technologists should coach patients carefully.
- Improper Dose Modulation: Using a standard diagnostic CT protocol by mistake delivers unnecessarily high radiation. The protocol must be explicitly “low-dose” and verified.
- Ignoring Patient Size: While 100 kVp is common, very large patients may require 120 kVp to ensure adequate photon penetration and avoid excessive image noise, even with iterative reconstruction.
- Missing Priors: The interpreting radiologist MUST have access to all prior screening CTs. A read without comparison is an incomplete study and a patient safety risk.
9. The 3-Months-Free Offer for Radiology Residents and Fellows
3+ months free for radiology residents and fellows
Look like a rockstar on your reports — dictate positive findings in free form, and the AI generates a structured report using ACR + SIR templates with the appropriate clinical decision support firing automatically. We built this to be the tool we wish we had during training.
All we ask in return is your feedback so we can keep improving the product for trainees. The setup is simple. There is no credit card required and no long forms to fill out.
To get set up, just reply to the application with these three items:
- Your PGY year (e.g., PGY-2, PGY-4)
- Your training type (radiology residency or specific fellowship)
- Your training program / hospital name
That’s it. You can apply for the residents free-access program here.
10. Frequently Asked Questions
Is GigHz Precision AI HIPAA-compliant?
Yes. The platform is designed for de-identified workflows by default. No patient-identifying information is required or stored, ensuring compliance with HIPAA privacy and security standards.
Do I need my hospital’s IT department to set this up?
No. GigHz Precision AI is browser-based and requires no local software installation or special permissions. It works on any modern computer, including the call-room PC or your personal iPad.
How does this work with PowerScribe or other dictation systems?
It works alongside your existing dictation system. You can dictate your findings as you normally would, and the platform generates the structured text. You can then copy and paste the final, clean report into your PACS/RIS with a single click.
Can I use my own custom templates?
Yes. While the system comes pre-loaded with ACR and society-endorsed templates, you can customize them or upload your own preferred macros to fit your workflow and your attendings’ preferences.
What happens after my residency or fellowship ends?
You can choose to transition to a paid plan for practicing radiologists. We offer discounts for recent graduates to help you get started in your new role without a significant financial burden.
Is this available on a mobile device?
Yes, the platform is fully responsive and works on tablets like the iPad, making it easy to use in the reading room, on call, or wherever you’re working.
Free GigHz Tools That Pair With This Article
Three free tools that complement the material above:
- ACR Appropriateness Criteria Lookup — Type an indication or clinical scenario in plain language and get the imaging studies the ACR rates for it, with adult and pediatric radiation levels. Built directly from 297 ACR topics, 1,336 clinical variants, and 15,823 procedure ratings.
- GigHz Imaging Protocol Library — A searchable library of 131 imaging protocols with the physics specs surfaced and the matching ACR Appropriateness Criteria alongside. Plain-English narratives readable in 60 seconds, organized by modality.
- GigHz Radiation Dose Calculator — Pick the imaging studies a patient has had and see total dose in millisieverts (mSv) with comparisons to natural background radiation, transatlantic flights, and chest X-rays. Useful for shared decision-making.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 7, 2026
